The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

December 15, 2016 • By Charles Radis, DO

  • Tweet
  • Email
Print-Friendly Version / Save PDF

I jot down her medical and social history on a separate yellow sheet: Depression treated with amitriptyline in 1984, mild asthma, chronic insomnia, divorce in 1985, two children ages 8 and 11, non-smoker, rare alcohol use. Let’s see: silicone breast augmentation in 1988, remarried in 1989, currently not working out of the home.

You Might Also Like
  • Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
  • Somatic Mosaicism Can Complicate Diagnosis of Autoimmune Disease
  • When Symptoms of Rheumatic Disorder Point to Endocrine Disease
Explore This Issue
December 2016
Also By This Author
  • The Case of a 13-Year-Old Girl with Life-Threatening Lupus Onset

I flip to the tab titled Lab. Over the years, the majority of her lab tests were routine—the type of blood work one might draw for a yearly physical. Blood counts, thyroid studies, chemistry profiles, liver and kidney function: normal. Testing for Epstein-Barr virus, chronic hepatitis and HIV. Hmm, that’s a little out of the ordinary. Extensive viral testing is usually reserved for patients who feel unwell. They were drawn in 1986, two years before breast augmentation and then again in 1990. Normal and normal.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I scan down the tests evaluating Mrs. Morse’s markers for systemic inflammation—an erythrocyte sedimentation rate (ESR), normal at 17, and several C-reactive proteins (CRPs), one of which was borderline abnormal at 1.3 mg/dL (this was highlighted with a “!!!!” by the law firm in yellow marker).

The immunologic studies follow: A series of anti-nuclear antibody (ANA) tests were listed, several going back to the mid-1980s. I look these over more carefully. The presence of ANA may be associated with various autoimmune diseases, but they are not diagnostic of autoimmune disease. Numerous studies have documented that an ANA can be detected in the blood of patients with infection, with certain medications and, at times, in healthy adults. There were five ANA blood tests reported, two before Mrs. Morse’s breast implants in 1988, both negative, and three subsequently, only the last of which was positive at a low level. This was also boldly underlined in yellow with a comment: “SLE test positive.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

I take a closer look at the identifying lab information at the top of the sheet. The most recent positive ANA was performed at a specialty lab I was unfamiliar with in faraway Louisiana. That’s strange. There are plenty of good reference labs in Maine. If you want to be picky, the Mass General Hospital has an excellent lab for immunology. But to send a lab specimen all the way to Louisiana? Below the ANA were several additional tests assessing for the presence of antibodies against silicone. These were markedly positive, with an asterisk over the values. In fine print at the bottom of the page, a corresponding asterisk divulged “silicone antibodies are performed in house and have not been validated by an outside independent lab.” Next to the silicone antibody values was another breathless, yellow exclamation mark.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Autoimmune disease, breast implant, Diagnosis, Lupus, patient care, physician, rheumatologist, silicone, SLE, symptomIssue: December 2016

You Might Also Like:
  • Is B a Key to Autoimmune Therapy?: B Cell–targeted Therapies in Autoimmune Disease
  • Somatic Mosaicism Can Complicate Diagnosis of Autoimmune Disease
  • When Symptoms of Rheumatic Disorder Point to Endocrine Disease
  • 2013 ACR/ARHP Annual Meeting: Clues to Predictors of Autoimmune Disease Revealed

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.